KFAR SABA, ISRAEL – October 1st, 2016 – Colospan Ltd., a company developing revolutionary solutions for colorectal surgery, announced that was selected to be a presenter the Emerging Medical Technologies (EMT) Summit on November 9-11, 2016, located at the heart of the medical technology development and investment hub in California’s Silicon Valley.
The prestigious EMT Summit was co-hosted by Life Science Intelligence and the MedTech Strategist, and featured presentations by CEOs of 70 hand-picked early-stage medical device companies from around the world, raising capital and/or seeking quality strategic partners. Additional top-tier supporting organizations including sponsors Johnson & Johnson, Medmarc, Knobbe Martens, 3M and Olympus, PMI, BioQuest, IMMR and Venta Medical.
The summit’s audience included top medical device VCs and business development executives, along with management teams from many of the most promising start-ups in the medical device space.
Colospan Ltd., is a clinical stage medical device company focusing on the development of novel and proprietary solutions for colorectal surgery. The company is dedicated to addressing the profound clinical and economic pains associated with anastomotic leaks, the first and foremost challenge in colorectal surgery. Colospan’s lead product, CG-100, intends to offer a safe, effective alternative for the ostomy pouch, to improve medical procedures, reduce health risks and enable patients to maintain dignity post-surgery. Colospan’s team consists of seasoned professionals in marketing, sales and development of surgical devices for colorectal surgery, supported by a of key opinion leaders (KOLs) from Europe and the United States. Colospan holds a CE mark for gastro-intestinal devices as well as ISO 13485 certification.